Pharmaceutical Outsourcing Q3 2023 - 5

JULY/AUGUST/SEPTEMBER 2023 | VOLUME 24, ISSUE 3
In this Issue
12 | CONTRACT RESEARCH
In-Flight Data Control: Key to Efficient Life Sciences Business Processes
Max Kelleher, Chief Operating Officer
Generis
Remco Munnik, Director
Iperion, a Deloitte business
16 | CLINICAL TRIALS
Most Significant Risk Factors for Emerging and Mid-Market Biopharma
Companies - Costly Clinical Trial Delays
Dr. Harsha K Rajasimha, MS, Ph.D., Founder
Jeeva Informatics Solutions Inc.
Co-Authored by Dr. Padma Rammoorthy
22 | CONTRACT MANUFACTURING
Four Questions to Determine the Health of Your Company's QMS
Michelle Anastasi, Director of Quality and Compliance
PharmaLex US
Contact Us
24 | CLINICAL TRIALS
Transitioning to Precision Medicine
Christian Olsen, Associate VP, Industry Principal, Biologics
Dotmatics
28 | CONTRACT MANUFACTURING
The Power of Solubilization - How CDMOs Help Low Solubility Drug
Candidates Reach Their Full Potential
Dr. Robert W. Lee, President
Lubrizol Life Science Health - CDMO Division
cdmo@eurofins.com
+1-905-403-0477
PARTNER
WITH US
TO RAPIDLY
DEVELOP A
FORMULATION
THAT IS BEST
SUITED FOR
YOUR
DRUG
DEVELOPMENT
PROGRAM
REGULAR FEATURES
2
6
EDITOR'S MESSAGE
EDITORIAL ADVISORY BOARD
34 HORIZON LINES
37 INDUSTRY NEWS
40 ADVERTISER'S INDEX
SPECIAL FEATURES
8 CN PERSPECTIVES
9 SOCIAL MEDIA CONNECTIONS
32 PHARMSCI 360
TRADE SHOW PREVIEW
40 FEATURED EVENTS
pharmoutsourcing.com | 5 | July/August/September 2023

http://www.pharmoutsourcing.com

Pharmaceutical Outsourcing Q3 2023

Table of Contents for the Digital Edition of Pharmaceutical Outsourcing Q3 2023